会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 23. 发明申请
    • Medical Device and Its use
    • 医疗器械及其用途
    • US20080118579A1
    • 2008-05-22
    • US11666297
    • 2005-11-02
    • Hannu JarvelainenMatti LaatoJukka SalonenErik Vedel
    • Hannu JarvelainenMatti LaatoJukka SalonenErik Vedel
    • A61K33/06A61P17/02A61K33/00A61K33/32A61K31/69A61K31/665
    • A61L15/18A61K9/0024A61K9/1611A61L27/10C03C3/078C03C4/0007C03C4/0014
    • The invention relates to a medical device comprising non-sintered bioactive glass particles or fibres having a diameter in the range 5-100 μm, bioactive glass comprising SiO2, Na2O, CaO, K2O, MgO, B2O3 and P2O5, wherein the amount of SiO2 is 50-65 wt-% of the final total weight, Na2O is 5-26 wt-% of the final total weight, CaO is 10-25 wt-% of the final total weight, K2O is 0-15 wt-% of the final total weight, MgO is 0-6 wt-% of the final total weight, B2O3 is 0-4 wt-% of the final total weight, and P2O5 is 0-4 wt-% of the final total weight, provided that the total amount of Na2O and K2O is 10-30 wt-% of the final total weight The device is essentially drug free. The invention also relates to the use of said composition for treating lesions associated with compromised or poor vascularisation and for preventing avascular fibrosis.
    • 本发明涉及包含非烧结生物活性玻璃颗粒或直径在5-100μm范围内的纤维的医疗装置,包含SiO 2,Na 2 O 2的生物活性玻璃 ,CaO,K 2 O,MgO,B 2 O 3和P 2 O 5, / SUB>,其中SiO 2的量为最终总重量的50-65重量%,Na 2 O 2为最终总重量的5-26重量% 总重量,CaO为最终总重量的10-25重量%,K 2 O 2为最终总重量的0-15重量%,MgO为0-6重量% 最终总重量,B 2 O 3 O 3是最终总重量的0-4重量%,P 2 O 5 如果Na 2 O 2和K 2 O 2的总量为10-30重量%,则其最终总重量为0-4重量% 最终总重量的百分比该装置基本上是无毒的。 本发明还涉及所述组合物用于治疗与受损或差的血管形成相关的损伤并用于预防无血管纤维化的用途。